ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AKBA Akebia Therapeutics Inc

1.36
-0.02 (-1.45%)
20 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Akebia Therapeutics Inc AKBA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.02 -1.45% 1.36 09:44:59
Open Price Low Price High Price Close Price Previous Close
1.35 1.31 1.38 1.36 1.38
more quote information »

Recent News

Date Time Source Heading
03/4/202407:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
28/3/202411:26PRNUSAkebia Receives FDA Approval of Vafseo® (vadadustat) Tablets..
15/3/202407:15PRNUSAkebia Therapeutics Reports Fourth Quarter and Full Year..
12/3/202408:05PRNUSAkebia Therapeutics to Report Fourth Quarter and Full Year..
02/3/202409:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202409:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202409:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202409:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202408:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
01/3/202410:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202410:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202410:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202408:32EDGAR2Form 144 - Report of proposed sale of securities
01/3/202408:28EDGAR2Form 144 - Report of proposed sale of securities
01/3/202408:27EDGAR2Form 144 - Report of proposed sale of securities
28/2/202410:19EDGAR2Form 144 - Report of proposed sale of securities
28/2/202410:14EDGAR2Form 144 - Report of proposed sale of securities
28/2/202410:11EDGAR2Form 144 - Report of proposed sale of securities
14/2/202400:00EDGAR2Form 8-K - Current report
03/2/202408:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
02/2/202408:52EDGAR2Form 144 - Report of proposed sale of securities
31/1/202408:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
31/1/202400:05EDGAR2Form 8-K - Current report
31/1/202400:00PRNUSAkebia Secures $55 Million Term Loan Financing
19/1/202409:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/1/202400:30PRNUSAkebia Therapeutics Announces Appointment of Nicholas Grund..
09/1/202408:08EDGAR2Form 8-K - Current report
09/1/202400:02EDGAR2Form 8-K - Current report
03/1/202408:30PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
21/12/202300:00PRNUSAkebia Therapeutics to Present at the 42nd Annual J.P...
19/12/202308:07EDGAR2Form 8-K - Current report
02/12/202308:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
22/11/202309:07EDGAR2Form 8-K - Current report
21/11/202300:00PRNUSAkebia Therapeutics to Present at Piper Sandler Healthcare..
08/11/202323:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202323:33EDGAR2Form 8-K - Current report
08/11/202323:30PRNUSAkebia Therapeutics Reports Third Quarter 2023 Financial..
03/11/202307:34EDGAR2Form 8-K - Current report
03/11/202307:30PRNUSAkebia Therapeutics Announces Favorable Payment Term..
02/11/202307:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
31/10/202323:00PRNUSAkebia Therapeutics to Report Third Quarter 2023 Financial..
26/10/202307:06EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock